Surgical strategy in the treatment of pancreatic neuroendocrine tumors

Journal of the Pancreas

Volumn 7, Issue 1, 2006, Pages 150-156

  Falconi, Massimo ^a   Bettini, Rossella ^a   Boninsegna, Letizia ^a   Crippa, Stefano ^a   Butturini, Giovanni ^a   Pederzoli, Paolo ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Neuroendocrine tumors; Operative; Pancreatic neoplasms; Surgical procedures

Indexed keywords

ARTICLE; CANCER INVASION; CHOLECYSTECTOMY; ECHOGRAPHY; GASTRINOMA; HUMAN; INSULINOMA; INTRAOPERATIVE PERIOD; LIVER; LIVER TRANSPLANTATION; LIVER TUMOR; METASTASIS; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; PANCREAS; PANCREAS TUMOR; PATHOLOGY;

CHOLECYSTECTOMY; GASTRINOMA; HUMANS; INSULINOMA; INTRAOPERATIVE PERIOD; LIVER; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEUROENDOCRINE TUMORS; PANCREAS; PANCREATIC NEOPLASMS;

EID: 33745534897     PISSN: 15908577     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97:934-59. [PMID 12569593]
2. Eriksson B, Arnberg H, Lindgren PG, Lorelius LE, Magnusson A, Lundqvist G, et al. Neuroendocrine pancreatic tumours: clinical presentation, biochemical and histopathological findings in 84 patients. J Intern Med 1990; 228:103-13. [PMID 2168468]
3. Solcia E, Kloppel G, Sobin L. Histological typing of the endocrine tumours. Berlin Heidelberg: Springer-Verlag; 2000.
4. Norton JA, Fraker DL, Alexander HR, Venzon DJ, Doppman JL, Serrano J, et al. Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med 1999; 341:635-44. [PMID 10460814]
5. Prinz RA. Localization of gastrinomas. Int J Pancreatol 1996; 19:79-91. [PMID 8723550]
6. Rothmund M. Localization of endocrine pancreatic tumours. Br J Surg 1994; 81:164-6. [PMID 8156325]
7. Norton JA, Cromack DT, Shawker TH, Doppman JL, Comi R, Gorden P, et al. Intraoperative ultrasonographic localization of islet cell tumors. A prospective comparison to palpation. Ann Surg 1988; 207:160-8. [PMID 2829761]
8. Klotter HJ, Ruckert K, Kummerle F, Rothmund M. The use of intraoperative sonography in endocrine tumors of the pancreas. World J Surg 1987; 11:635-41. [PMID 2823490]
9. Sugg SL, Norton JA, Fraker DL, Metz DC, Pisegna JR, Fishbeyn V, et al. A prospective study of intraoperative methods to diagnose and resect duodenal gastrinomas. Ann Surg 1993; 218:138-44. [PMID 8342993]
10. Norton JA, Doppman JL, Jensen RT. Curative resection in Zollinger-Ellison syndrome: results of a ten year prospective study. Ann Surg 1992; 215:8-18. [PMID 1531004]
11. Norton JA. Neuroendocrine tumors of the pancreas and duodenum. Curr Probl Surg 1994; 31:77-156. [PMID 7904550]
12. Delcore R, Friesen SR. Gastrointestinal neuroendocrine tumors. J Am Coll Surg 1994; 178:187-211. [PMID 8173736]
13. Vinik AI, Moattari AR. Treatment of endocrine tumors of the pancreas. Endocrinol Metab Clin North Am 1989; 18:483-518. [PMID 2663483]
14. Peplinski GR, Skinner MA, Norton JA. Insulinoma and nesidioblastosis. In: Howard J, Idezuki Y, Ihse I, Prinz R, eds. Surgical Disease of the Pancreas, 3rd Ed. Baltimore, MD, USA: Williams and Wilkins, 1998:717-32. [ISBN 0-683-18019-3]
15. Van Heerden J. The surgical treatment of insulinomas. In: Beger HG, Warshaw Al, Buchler MW, Carr-Locke DL, Neoptolemos JP, C RussellC, eds. The Pancreas. Oxford, UK: Blackwell Science, 1998:1203-12. [ISBN 865424209]
16. Miller DL. Endocrine angiography and venous sampling. Radiol Clin North Am 1993; 31:1051-67. [PMID 8362055]
17. Brennan MF, Jensen RT, Wesley RA, Doppman JL, McCarthy DM. The role of surgery in patients with Zollinger-Ellison syndrome (ZES) managed medically. Ann Surg 1982; 196:239-45. [PMID 7114932]
18. Park BJ, Alexander HR, Libutti SK, Huang J, Royalty D, Skarulis MC, et al. Operative management of islet-cell tumors arising in the head of the pancreas. Surgery 1998; 124:1056-61. [PMID 9854583]
19. Stadil F. Treatment of gastrinomas with pancreaticoduodenectomy. In: Jensen RT, Mignon M, eds. Endocrine Tumors of the Pancreas: Recent Advances in Research and Management. Basel, Switzerland: Karger, 1994:333-41.
20. Delcore R, Friesen SR. Role of pancreatoduodenectomy in the management of primary duodenal wall gastrinomas in patients with Zollinger- Ellison syndrome. Surgery 1992; 112:1016-22. [PMID 1360709]
21. Phan GQ, Yeo CJ, Hruban RH, Lillemoe KD, Pitt HA, Cameron JL. Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients. J Gastrointest Surg 1998; 2:472-82. [PMID 9843608]
22. Jordan PH Jr. A personal experience with pancreatic and duodenal neuroendocrine tumors. J Am Coll Surg 1999; 189:470-82. [PMID 10549736]
23. Dial PF, Braasch JW, Rossi RL, Lee AK, Jin GL. Management of nonfunctioning islet cell tumors of the pancreas. Surg Clin North Am 1985; 65:291-9. [PMID 2990058]
24. Madura JA, Cummings OW, Wiebke EA, Broadie TA, Goulet RL Jr, Howard TJ. Nonfunctioning islet cell tumors of the pancreas: a difficult diagnosis but one worth the effort. Am Surg 1997; 63:573-7. [PMID 9202529]
25. Bartsch DK, Schilling T, Ramaswamy A, Gerdes B, Celik I, Wagner HJ, et al. Management of nonfunctioning islet cell carcinomas. World J Surg 2000; 24:1418-24. [PMID 11038216]
26. Matthews BD, Heniford BT, Reardon PR, Brunicardi FC, Greene FL. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas. Am Surg 2000; 66:1116-22. [PMID 11149582]
27. Norton JA, Sugarbaker PH, Doppman JL, Wesley RA, Maton PN, Gardner JD, Jensen RT. Aggressive resection of metastatic disease in selected patients with malignant gastrinoma. Ann Surg 1986; 203:352-9. [PMID 2938550]
28. McEntee GP, Nagorney DM, Kvols LK, Moertel CG, Grant CS. Cytoreductive hepatic surgery for neuroendocrine tumors. Surgery 1990; 108:1091-6. [PMID 1701060]
29. Danforth DN Jr, Gorden P, Brennan MF. Metastatic insulin-secreting carcinoma of the pancreas: clinical course and the role of surgery. Surgery 1984; 96:1027-37. [PMID 6095477]
30. Carty SE, Jensen RT, Norton JA. Prospective study of aggressive resection of metastatic pancreatic endocrine tumors. Surgery 1992; 112:1024-31. [PMID 1455305]
31. Chamberlain RS, Canes D, Brown KT, Saltz L, Jarnagin W, Fong Y, Blumgart LH. Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg 2000; 190:432-45. [PMID 10757381]
32. Chen H, Hardacre JM, Uzar A, Cameron JL, Choti MA. Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg 1998; 187:88-92. [PMID 9660030]
33. Evans DB, Skibber JM, Lee JE, Cleary KR, Ajani JA, Gagel RF, et al. Nonfunctioning islet cell carcinoma of the pancreas. Surgery 1993; 114:1175-81. [PMID 7903005]
34. Pederzoli P, Falconi M, Bonora A, Salvia R, Sartori N, Contro C, et al. Cytoreductive surgery in advanced endocrine tumours of the pancreas. Ital J Gastroenterol Hepatol 1999; 31(Suppl 2):S207-12. [PMID 10604132]
35. Speer AG, Cotton PB, Russell RC, Mason RR, Hatfield AR, Leung JW, et al. Randomised trial of endoscopic versus percutaneous stent insertion in malignant obstructive jaundice. Lancet 1987; 2:57-62. [PMID 2439854]
36. Andersen JR, Sorensen SM, Kruse A, Rokkjaer M, Matzen P. Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut 1989; 30:1132-5. [PMID 2475392]
37. Welvaart K. Operative bypass for incurable cancer of the head of the pancreas. Eur J Surg Oncol 1992; 18:353-6. [PMID 1381687]
38. Falconi M, Bassi C, Bonora A, Sartori N, Procacci C, Talamini G, et al. Role of chemoembolization in synchronous liver metastases from pancreatic endocrine tumours. Dig Surg 1999; 16:32-8. [PMID 99136138]
39. Mavligit GM, Pollock RE, Evans HL, Wallace S. Durable hepatic tumor regression after arterial chemoembolization-infusion in patients with islet cell carcinoma of the pancreas metastatic to the liver. Cancer 1993; 72:375-80. [PMID 93306579]
40. Nesovic M, Ciric J, Radojkovic S, Zarkovic M, Durovic M. Improvement of metastatic endocrine tumors of the pancreas by hepatic artery chemoembolization. J Endocrinol Invest 1992; 15:543-7. [PMID 93077918]
41. Marlink RG, Lokich JJ, Robins JR, Clouse ME. Hepatic arterial embolization for metastatic hormonesecreting tumors. Technique, effectiveness, and complications. Cancer 1990; 65:2227-32. [PMID 90268389]
42. Ruszniewski P, Rougier P, Roche A, Legmann P, Sibert A, Hochlaf S, et al. Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients. Cancer 1993; 71:2624-30. [PMID 93201492]
43. Clouse ME, Perry L, Stuart K, Stokes KR. Hepatic arterial chemoembolization for metastatic neuroendocrine tumors. Digestion 1994; 55(Suppl 3):92-7. [PMID 95212792]
44. Eriksson BK, Larsson EG, Skogseid BM, Lofberg AM, Lorelius LE, Oberg KE. Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors. Cancer 1998; 83:2293-301. [PMID 99054263]
45. Wiedenmann B, Jensen RT, Mignon M, Modlin CI, Skogseid B, Doherty G, et al. Preoperative diagnosis and surgical management of neuroendocrine gastroenteropancreatic tumors: general recommendations by a consensus workshop. World J Surg 1998; 22:309-18. [PMID 98155529]
46. Oberg K. State of the art and future prospects in the management of neuroendocrine tumors. Q J Nucl Med 2000; 44:3-12. [PMID 20387969]
47. Lang H, Oldhafer KJ, Weimann A, Schlitt HJ, Scheumann GF, Flemming P, et al. Liver transplantation for metastatic neuroendocrine tumors. Ann Surg 1997; 225:347-54. [PMID 9114792]
48. Frilling A, Rogiers X, Malago M, Liedke O, Kaun M, Broelsch CE. Liver transplantation in patients with liver metastases of neuroendocrine tumors. Transplant Proc 1998; 30:3298-300. [PMID 99055837]
49. Le Treut YP, Delpero JR, Dousset B, Cherqui D, Segol P, Mantion G, et al. Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report. Ann Surg 1997; 225:355-64. [PMID 9114793]
50. Trendle MC, Moertel CG, Kvols LK. Incidence and morbidity of cholelithiasis in patients receiving chronic octreotide for metastatic carcinoid and malignant islet cell tumors. Cancer 1997; 79:830-4. [PMID 9024721]
51. Jensen RT. Pancreatic endocrine tumors: recent advances. Ann Oncol 1999; 10(Suppl 4):170-6. [PMID 99365868]
52. Weber HC, Venzon DJ, Lin JT, Fishbein VA, Orbuch M, Strader DB, et al. Determinants of metastatic rate and survival in patients with Zollinger-Ellison syndrome: a prospective long-term study. Gastroenterology 1995; 108:1637-49. [PMID 7768367]
53. Mignon M, Cadiot G. Diagnostic and therapeutic criteria in patients with Zollinger-Ellison syndrome and multiple endocrine neoplasia type 1. J Intern Med 1998; 243:489-94. [PMID 9681847]
54. Skogseid B, Oberg K, Eriksson B, Juhlin C, Granberg D, Akerstrom G, et al. Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type I. World J Surg 1996; 20:872-6. [PMID 8678965]
55. Thompson NW. Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease. Results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both. J Intern Med 1998; 243:495-500. [PMID 9681848]